Abhishek Singh CEO Taj Pharmaceuticals India states that; there is a general awareness about the, CIS Region (Commonwealth of Independent States)

1. Expanding business and trade with CIS Region
— Healthcare {Taj Pharmaceuticals}
Taj Pharmaceuticals India
Taj Pharma Manufacturing
Abhishek Singh CEO Taj Pharmaceuticals
India states that; there is a general
awareness about the, CIS Region
(Commonwealth of Independent States)
MUMBAI, MAHARASHTRA, INDIA, June
12, 2020 /EINPresswire.com/ -- India’s
major healthcare exports to CIS
countries includes Pharmaceutical
products, Electrical machinery and
equipment and parts thereof,
Machinery, Mechanical appliances,
Organic chemicals; Coffee, tea, spices,
Vehicles other than railway or tramway
rolling stock, and parts and accessories
thereof, Iron and steel etc.
Abhishek Singh CEO Taj
Pharmaceuticals India states that;
there is a general awareness about the,
CIS Region (Commonwealth of
Independent States) consists of 12
countries namely Kazakhstan,
Turkmenistan, Uzbekistan, Kyrgyzstan,
Tajikistan, Russian Federation, Georgia,
Azerbaijan, Armenia, Ukraine, Belarus
and Moldova.
It is observed that in spite of large
market size and great potential, India’s
exports to the CIS region was USD 5.3
Billion in 2019, and constituted only
1.2% in overall CIS imports. In order to
enhance India’ share and volume in CIS imports, Department of Commerce has requested to

2. Taj Pharma India
identify the issues/reasons for low
penetration and measures required to
be taken to increase our trade.
In case you have any
inputs/suggestions in this regard,
kindly send us the same(Country wise)
latest by June 20th, 2020 at info ( @ )
tajpharma dot com to enable us to
forward the same to the Indian
Ministry’s so that the same can be
taken up with the respective
authorities dot
About Taj Pharma Russia and CIS
operations (ТАДЖ ФАРМА)
TAJ PHARMA CIS (ТАДЖ ФАРМА) is Russia’s leading innovative Generics and branded
Pharmaceuticals Company; it combines a world-class research and development center, ultra-
modern pharmaceutical and generics manufacturing facilities, as well as preclinical and clinical
Taj Pharmaceutical an
Industrial conglomerate,
having diversified interest in
Pharmaceuticals and
healthcare, Chemicals, API
and Agro commodities
mainly offers unique
opportunities.”
Abhishek Kumar SIngh
research infrastructure compliant with international
standards to develop first generics.
TAJ PHARMA CIS (ТАДЖ ФАРМА) is one of the world`s few
full-cycle generic drug development and manufacturing
companies, from new molecule discovery and first bio-
similar’s to large-scale commercial production and
marketing support.
TAJ PHARMA CIS (ТАДЖ ФАРМА)`s medicines are
dedicated to treat complex health conditions such as renal
insufficiency, Cancer, Hepatitis C and HIV infections and
other disorders.
Taj Pharma CIS offers a range of “comprehensive” product registration, marketing authorization,
in-licensing and out-licensing of pharmaceuticals products; and holds expertise to register
pharmaceuticals products from formulation design up to international products registration and
distribution. We specialize in the marketing, distribution, product registration of an extensive
range of dosage forms and delivery systems including oral solids, controlled-release, steriles,
injectables, topicals, liquids, transdermals, semi-solids, Pre-filled syringes and high-potency
products.
We hold top positions in established Moscow and Turkmenistan, Baku, Azerbaijan, Kazakhstan

3. etc; with our unique products and are building a strong presence in many CIS markets.
Mr.Shantanu Kumar Singh
TAJ PHARMACEUTICALS LIMITED
+91 84484 44095
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
This press release can be viewed online at: https://www.einpresswire.com/article/519281316
EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors
try to be careful about weeding out false and misleading content. As a user, if you see something
we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire,
Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable
in today's world. Please see our Editorial Guidelines for more information.
© 1995-2020 IPD Group, Inc. All Right Reserved.